Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 150
Age Group: Child, Adult, Senior
Gender: All
Study Type: Observational
Study Design Allocation: Observational Model: Case-Only|Time Perspective: Retrospective
Study ID Numbers: ONC/OSS-02/2012
Study First Received: May 27, 2013
Last Updated: February 9, 2017
Estimated Primary Completion Date: December 2016
Primary Outcome Measures:
Expression of TUBB3 and BRCA1 in MPM tumor tissue by immunohistochemistry and RT-PCR.|Association of expression of TUBB3 and BRCA1 with clinical outcome (response, survival) .
Sponsors and Collaborators:
Armando Santoro, MD|Istituto Clinico Humanitas
Website Link: https://ClinicalTrials.gov/show/NCT01865045
